Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 20, Number 32, 2014

Articles

Favourites:
ADD

NMDA Pathology and Treatment of Schizophrenia
pp. 5118-5126(9)
Authors: Chang, Huey-Jen; Lane, Hsien-Yuan; E. Tsai, Guochuan

Favourites:
ADD

Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future
pp. 5127-5138(12)
Authors: Lin, Chun-Yuan; E. Tsai, Guochuan; Lane, Hsien-Yuan

Favourites:
ADD

Assessing Schizophrenia-relevant Cognitive and Social Deficits in Mice: A Selection of Mouse Behavioral Tasks and Potential Therapeutic Compounds
pp. 5139-5150(12)
Authors: Lai, Wen-Sung; Chang, Chia-Yuan; Wong, Wan-Rong; Pei, Ju-Chun; Chen, Ya-Shan; Hung, Wei-Li

Favourites:
ADD

Targeting of NMDA Receptors in the Treatment of Major Depression
pp. 5151-5159(9)
Authors: Dang, Yong-Hui; Ma, Xian-Cang; Zhang, Ji-Chun; Ren, Qian; Wu, Jin; Gao, Cheng-Ge; Hashimoto, Kenji

Favourites:
ADD

The Co-agonist Site of NMDA-glutamate Receptors: A Novel Therapeutic Target for Age-related Cognitive Decline
pp. 5160-5168(9)
Authors: Panizzutti, Rogerio; Scoriels, Linda; Avellar, Marcos

Favourites:
ADD

NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimer’s Disease
pp. 5169-5179(11)
Authors: Lin, Chieh-Hsin; Huang, Yu-Jhen; Lin, Chun-Jung; Lane, Hsien-Yuan; E. Tsai, Guochuan

Favourites:
ADD

Attention Deficit Hyperactivity Disorder and N-methyl-D-aspartate (NMDA) Dysregulation
pp. 5180-5185(6)
Authors: Pei-Chen Chang, Jane; Lane, Hsien-Yuan; E. Tsai, Guochuan

Favourites:
ADD

Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets
pp. 5186-5193(8)
Authors: Yang, Pinchen; Chang, Chen-Lin

Favourites:
ADD
Favourites:
ADD

Predicting Protein-Ligand Interactions Based on Chemical Preference Features with its Application to New D-Amino Acid Oxidase Inhibitor Discovery
pp. 5202-5211(10)
Authors: Zhao, Mingzhu; Chang, Hao-Teng; Zhou, Qiang; Zeng, Tao; Shih, Chung-Shiuan; Liu, Zhi-Ping; Chen, Luonan; Wei, Dong-Qing

Favourites:
ADD

Study on Gluco-Regulatory Potential of Glimepiride Sulfonamide Using In silico, In Vitro and In Vivo Approaches
pp. 5212-5217(6)
Authors: Singh Parmar, Hamendra; Kumar Bhinchar, Mahesh; Bhatia, Muskan; Chordia, Nikita; Raval, Ishan; Singh Chauhan, Digvijay; Manivannan, E.; Jatwa, Rameshwar; Kumar, Anil

Favourites:
ADD

Biological Carrier Molecules of Radiopharmaceuticals for Molecular Cancer Imaging and Targeted Cancer Therapy
pp. 5218-5244(27)
Authors: Aerts, A.; Impens, N.R.E.N.; Gijs, M.; D'Huyvetter, M.; Vanmarcke, H.; Ponsard, B.; Lahoutte, T.; Luxen, A.; Baatout, S.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content